tiprankstipranks
Trending News
More News >
Kobayashi Pharmaceutical Co (JP:4967)
:4967
Japanese Market

Kobayashi Pharmaceutical Co (4967) Income Statement

Compare
0 Followers

Kobayashi Pharmaceutical Co Income Statement

Last quarter (Q4 2024), Kobayashi Pharmaceutical Co's total revenue was ¥51.14B, a decrease of -5.89% from the same quarter last year. In Q4, Kobayashi Pharmaceutical Co's net income was ¥4.72B. See Kobayashi Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 165.60B¥ 173.46B¥ 166.26B¥ 155.25B¥ 150.51B
Gross Profit
¥ 87.60B¥ 96.38B¥ 92.33B¥ 88.77B¥ 85.27B
Operating Expenses
¥ 62.74B¥ 70.60B¥ 65.66B¥ 62.70B¥ 59.32B
Depreciation and Amortization
¥ 8.02B¥ 6.06B¥ 5.36B¥ 4.83B¥ 4.11B
EBITDA
¥ 32.73B¥ 33.65B¥ 31.86B¥ 30.79B¥ 29.91B
Operating Income
¥ 24.86B¥ 25.78B¥ 26.67B¥ 26.07B¥ 25.94B
Other Income/Expenses
¥ -10.95B¥ 1.78B¥ 1.28B¥ 1.57B¥ 692.00M
Pretax Income
¥ 13.91B¥ 27.56B¥ 27.95B¥ 27.64B¥ 26.64B
Net Income
¥ 10.07B¥ 20.34B¥ 20.02B¥ 19.71B¥ 19.20B
Per Share Metrics
Basic EPS
¥ 135.42¥ 268.16¥ 259.61¥ 252.35¥ 245.70
Diluted EPS
¥ 135.42¥ 268.16¥ 259.58¥ 252.35¥ 245.70
Weighted Average Shares Outstanding
74.34M 75.84M 77.12M 78.13M 78.16M
Weighted Average Shares Outstanding (Diluted)
74.34M 75.84M 77.13M 78.13M 78.16M
Currency in JPY

Kobayashi Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis